01181nas a2200217 4500000000100000008004100001260001300042653001200055653002100067653001100088653001200099653001700111100001600128700001900144245012800163300001000291490000700301050003200308520060900340022001400949 1976 d c1976 Jan10aDapsone10aErythema Nodosum10aHumans10aleprosy10aSulfonamides1 aEKAMBARAM V1 aVenkatachari S00aA trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L. a24-300 v48 aInfolep Library - available3 a

A trial of long-acting Sulphonamide RO.4-4393 (Fanasil) in the treatment of Lepromatous Leprosy patients with repeated E.N.L. is reported in this paper. There were 9 patients treated with Fanasil in this trial for a period of 2 years. The results of the trial have shown that the treatment with Fanasil helps to prevent the occurrence of E.N.L. under treatment with D.D.S. In addition, even after the completion of treatment with Fanasil, these patients seem to be stabilised and are able to tolerate D.D.S. But, the clinical and Bacteriological progress under Fanasil therapy is not satisfactory.

 a0024-1024